ReP USP - Resultado da busca

Artigo de periodico
Bleeding patterns of HIV-infected women using an etonogestrel-releasing contraceptive implant and efavirenz-based or lopinavir/ritonavir-based antiretroviral therapy (2016)
Ragazini, Conrado S.; Bahamondes, Maria Valeria; Prandini, Tatiana R. Rocha; Brito, Milena Bastos; Amaral, Eliana; Bahamondes, Luis; Duarte, Geraldo; Quintana, Silvana Maria; Ferriani, Rui Alberto; Vieira, Carolina Sales
Fonte: European Journal of Contraception and Reproductive Health Care. Unidade: FMRP
Assuntos: ANTI-HIV, INFECÇÕES POR HIV, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RAGAZINI, Conrado S. et al. Bleeding patterns of HIV-infected women using an etonogestrel-releasing contraceptive implant and efavirenz-based or lopinavir/ritonavir-based antiretroviral therapy. European Journal of Contraception and Reproductive Health Care, v. 21, n. 4, p. 285-289, 2016Tradução . . Disponível em: https://doi.org/10.1080/13625187.2016.1177718. Acesso em: 28 ago. 2024.
APA
Ragazini, C. S., Bahamondes, M. V., Prandini, T. R. R., Brito, M. B., Amaral, E., Bahamondes, L., et al. (2016). Bleeding patterns of HIV-infected women using an etonogestrel-releasing contraceptive implant and efavirenz-based or lopinavir/ritonavir-based antiretroviral therapy. European Journal of Contraception and Reproductive Health Care, 21( 4), 285-289. doi:10.1080/13625187.2016.1177718
NLM
Ragazini CS, Bahamondes MV, Prandini TRR, Brito MB, Amaral E, Bahamondes L, Duarte G, Quintana SM, Ferriani RA, Vieira CS. Bleeding patterns of HIV-infected women using an etonogestrel-releasing contraceptive implant and efavirenz-based or lopinavir/ritonavir-based antiretroviral therapy [Internet]. European Journal of Contraception and Reproductive Health Care. 2016 ; 21( 4): 285-289.[citado 2024 ago. 28 ] Available from: https://doi.org/10.1080/13625187.2016.1177718
Vancouver
Ragazini CS, Bahamondes MV, Prandini TRR, Brito MB, Amaral E, Bahamondes L, Duarte G, Quintana SM, Ferriani RA, Vieira CS. Bleeding patterns of HIV-infected women using an etonogestrel-releasing contraceptive implant and efavirenz-based or lopinavir/ritonavir-based antiretroviral therapy [Internet]. European Journal of Contraception and Reproductive Health Care. 2016 ; 21( 4): 285-289.[citado 2024 ago. 28 ] Available from: https://doi.org/10.1080/13625187.2016.1177718
Artigo de periodico
Chlamydia and gonorrhea in HIV-infected pregnant women and infant HIV transmission (2015)
Adachi, Kristina; Klausner, Jeffrey D; Bristow, Claire C; Xu, Jiahong; Ank, Bonnie; Morgado, Mariza G; Watts, D. Heather; Weir, Fred; Persing, David; Mofenson, Lynne M; Veloso, Valdilea G; Pilotto, Jose Henrique; Joao, Esau; Nielsen-Saines, Karin; Mussi-Pinhata, Marisa Márcia; Duarte, Geraldo; Bárbaro, Adriana Aparecida Tiraboschi; Vieira, Carolina Sales
Fonte: Sexually Transmitted Diseases. Unidade: FMRP
Assuntos: CHLAMYDIA, DOENÇAS SEXUALMENTE TRANSMISSÍVEIS, SÍNDROME DE IMUNODEFICIÊNCIA ADQUIRIDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ADACHI, Kristina et al. Chlamydia and gonorrhea in HIV-infected pregnant women and infant HIV transmission. Sexually Transmitted Diseases, v. 42, n. 10, p. 554-565, 2015Tradução . . Disponível em: https://doi.org/10.1097/OLQ.0000000000000340. Acesso em: 28 ago. 2024.
APA
Adachi, K., Klausner, J. D., Bristow, C. C., Xu, J., Ank, B., Morgado, M. G., et al. (2015). Chlamydia and gonorrhea in HIV-infected pregnant women and infant HIV transmission. Sexually Transmitted Diseases, 42( 10), 554-565. doi:10.1097/OLQ.0000000000000340
NLM
Adachi K, Klausner JD, Bristow CC, Xu J, Ank B, Morgado MG, Watts DH, Weir F, Persing D, Mofenson LM, Veloso VG, Pilotto JH, Joao E, Nielsen-Saines K, Mussi-Pinhata MM, Duarte G, Bárbaro AAT, Vieira CS. Chlamydia and gonorrhea in HIV-infected pregnant women and infant HIV transmission [Internet]. Sexually Transmitted Diseases. 2015 ; 42( 10): 554-565.[citado 2024 ago. 28 ] Available from: https://doi.org/10.1097/OLQ.0000000000000340
Vancouver
Adachi K, Klausner JD, Bristow CC, Xu J, Ank B, Morgado MG, Watts DH, Weir F, Persing D, Mofenson LM, Veloso VG, Pilotto JH, Joao E, Nielsen-Saines K, Mussi-Pinhata MM, Duarte G, Bárbaro AAT, Vieira CS. Chlamydia and gonorrhea in HIV-infected pregnant women and infant HIV transmission [Internet]. Sexually Transmitted Diseases. 2015 ; 42( 10): 554-565.[citado 2024 ago. 28 ] Available from: https://doi.org/10.1097/OLQ.0000000000000340
Artigo de periodico
Effect of antiretroviral therapy including lopinavir/ritonavir or efavirenz on etonogestrel-releasing implant pharmacokinetics in HIV-positive women (2014)
Vieira, Carolina Sales; Bahamondes, Maria Valeria; Souza, Roberto Molina de; Brito, Milena Bastos; Prandini, Tatiana Roberti Rocha; Amaral, Eliana; Bahamondes, Luis; Duarte, Geraldo; Quintana, Silvana Maria; Scaranari, Carolina; Ferriani, Rui Alberto
Fonte: Journal of Acquired Immune Deficiency Syndromes. Unidade: FMRP
Assuntos: INFECÇÕES POR HIV, FARMACOTERAPIA, FARMACOCINÉTICA, MULHERES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIEIRA, Carolina Sales et al. Effect of antiretroviral therapy including lopinavir/ritonavir or efavirenz on etonogestrel-releasing implant pharmacokinetics in HIV-positive women. Journal of Acquired Immune Deficiency Syndromes, v. 66, n. 4, p. 378–385, 2014Tradução . . Disponível em: https://doi.org/10.1097/QAI.0000000000000189. Acesso em: 28 ago. 2024.
APA
Vieira, C. S., Bahamondes, M. V., Souza, R. M. de, Brito, M. B., Prandini, T. R. R., Amaral, E., et al. (2014). Effect of antiretroviral therapy including lopinavir/ritonavir or efavirenz on etonogestrel-releasing implant pharmacokinetics in HIV-positive women. Journal of Acquired Immune Deficiency Syndromes, 66( 4), 378–385. doi:10.1097/QAI.0000000000000189
NLM
Vieira CS, Bahamondes MV, Souza RM de, Brito MB, Prandini TRR, Amaral E, Bahamondes L, Duarte G, Quintana SM, Scaranari C, Ferriani RA. Effect of antiretroviral therapy including lopinavir/ritonavir or efavirenz on etonogestrel-releasing implant pharmacokinetics in HIV-positive women [Internet]. Journal of Acquired Immune Deficiency Syndromes. 2014 ; 66( 4): 378–385.[citado 2024 ago. 28 ] Available from: https://doi.org/10.1097/QAI.0000000000000189
Vancouver
Vieira CS, Bahamondes MV, Souza RM de, Brito MB, Prandini TRR, Amaral E, Bahamondes L, Duarte G, Quintana SM, Scaranari C, Ferriani RA. Effect of antiretroviral therapy including lopinavir/ritonavir or efavirenz on etonogestrel-releasing implant pharmacokinetics in HIV-positive women [Internet]. Journal of Acquired Immune Deficiency Syndromes. 2014 ; 66( 4): 378–385.[citado 2024 ago. 28 ] Available from: https://doi.org/10.1097/QAI.0000000000000189
Trabalho de evento-resumo periodico
Effect of antiretroviral therapy including lopinavir/ritonavir or efavirenz on the etonogestrel-releasing implant pharmacokinetics in HIV-infected women (2014)
Vieira, Carolina Sales; Bahamondes, Maria Valeria; Souza, Roberto; Brito, Milena; Prandini, Tatiana; Amaral, Eliana; Bahamondes, Luis; Duarte, Geraldo; Quintana, Silvana Maria; Scaranari, Carolina; Ferriani, Rui Alberto
Fonte: European Journal of Contraception and Reproductive Health Care. Nome do evento: Congress of the European Society of Contraception and Reproductive Health. Unidade: FMRP
Assuntos: INFECÇÕES POR HIV, FARMACOTERAPIA, FARMACOCINÉTICA, MULHERES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIEIRA, Carolina Sales et al. Effect of antiretroviral therapy including lopinavir/ritonavir or efavirenz on the etonogestrel-releasing implant pharmacokinetics in HIV-infected women. European Journal of Contraception and Reproductive Health Care. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 28 ago. 2024. , 2014
APA
Vieira, C. S., Bahamondes, M. V., Souza, R., Brito, M., Prandini, T., Amaral, E., et al. (2014). Effect of antiretroviral therapy including lopinavir/ritonavir or efavirenz on the etonogestrel-releasing implant pharmacokinetics in HIV-infected women. European Journal of Contraception and Reproductive Health Care. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Vieira CS, Bahamondes MV, Souza R, Brito M, Prandini T, Amaral E, Bahamondes L, Duarte G, Quintana SM, Scaranari C, Ferriani RA. Effect of antiretroviral therapy including lopinavir/ritonavir or efavirenz on the etonogestrel-releasing implant pharmacokinetics in HIV-infected women. European Journal of Contraception and Reproductive Health Care. 2014 ; 19 S72-S73.[citado 2024 ago. 28 ]
Vancouver
Vieira CS, Bahamondes MV, Souza R, Brito M, Prandini T, Amaral E, Bahamondes L, Duarte G, Quintana SM, Scaranari C, Ferriani RA. Effect of antiretroviral therapy including lopinavir/ritonavir or efavirenz on the etonogestrel-releasing implant pharmacokinetics in HIV-infected women. European Journal of Contraception and Reproductive Health Care. 2014 ; 19 S72-S73.[citado 2024 ago. 28 ]
Trabalho de evento-resumo periodico
Immunologic effects of etonogestrel-releasing contraceptive implant in women living with human immunodeficiency virus (2012)
Milena, B.; Scaranari, C.; Ferriani, Rui Alberto; Bahamondes, L.; Bahamondes, V.; Quintana, Silvana Maria; Duarte, Geraldo; Amaral, E.; Vieira, Carolina Sales
Fonte: The European Journal of Contraception and Reproductive Health Care. Nome do evento: Congress of the European Society of Contraception and Reproductive Health. Unidade: FMRP
Assuntos: MULHERES, HIV, DISPOSITIVOS ANTICONCEPCIONAIS (EFEITOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MILENA, B. et al. Immunologic effects of etonogestrel-releasing contraceptive implant in women living with human immunodeficiency virus. The European Journal of Contraception and Reproductive Health Care. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 28 ago. 2024. , 2012
APA
Milena, B., Scaranari, C., Ferriani, R. A., Bahamondes, L., Bahamondes, V., Quintana, S. M., et al. (2012). Immunologic effects of etonogestrel-releasing contraceptive implant in women living with human immunodeficiency virus. The European Journal of Contraception and Reproductive Health Care. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Milena B, Scaranari C, Ferriani RA, Bahamondes L, Bahamondes V, Quintana SM, Duarte G, Amaral E, Vieira CS. Immunologic effects of etonogestrel-releasing contraceptive implant in women living with human immunodeficiency virus. The European Journal of Contraception and Reproductive Health Care. 2012 ; 17 S44.[citado 2024 ago. 28 ]
Vancouver
Milena B, Scaranari C, Ferriani RA, Bahamondes L, Bahamondes V, Quintana SM, Duarte G, Amaral E, Vieira CS. Immunologic effects of etonogestrel-releasing contraceptive implant in women living with human immunodeficiency virus. The European Journal of Contraception and Reproductive Health Care. 2012 ; 17 S44.[citado 2024 ago. 28 ]
Artigo de periodico
Maternal antiretroviral use during pregnancy and infant congenital anomalies: the NISDI perinatal study (2010)
Joao, Esau C.; Calvet, Guilherme A.; Krauss, Margot R.; Hance, Laura Freimanis; Ortiz, Javier; Ivalo, Silvina A.; Pierre, Russell; Reyes, Mary; Heather Watts, D.; Read, Jennifer S.; Mussi-Pinhata, Marisa Márcia; Duarte, Geraldo; Macedo, Carolina Sales Vieira
Fonte: JAIDS - Journal of Acquired Immune Deficiency Syndromes. Unidade: FMRP
Assuntos: GRAVIDEZ, ANTI-HIV, INFECÇÕES POR HIV, COMPLICAÇÕES INFECCIOSAS NA GRAVIDEZ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JOAO, Esau C. et al. Maternal antiretroviral use during pregnancy and infant congenital anomalies: the NISDI perinatal study. JAIDS - Journal of Acquired Immune Deficiency Syndromes, v. 53, n. 2, p. 176-185, 2010Tradução . . Acesso em: 28 ago. 2024.
APA
Joao, E. C., Calvet, G. A., Krauss, M. R., Hance, L. F., Ortiz, J., Ivalo, S. A., et al. (2010). Maternal antiretroviral use during pregnancy and infant congenital anomalies: the NISDI perinatal study. JAIDS - Journal of Acquired Immune Deficiency Syndromes, 53( 2), 176-185.
NLM
Joao EC, Calvet GA, Krauss MR, Hance LF, Ortiz J, Ivalo SA, Pierre R, Reyes M, Heather Watts D, Read JS, Mussi-Pinhata MM, Duarte G, Macedo CSV. Maternal antiretroviral use during pregnancy and infant congenital anomalies: the NISDI perinatal study. JAIDS - Journal of Acquired Immune Deficiency Syndromes. 2010 ; 53( 2): 176-185.[citado 2024 ago. 28 ]
Vancouver
Joao EC, Calvet GA, Krauss MR, Hance LF, Ortiz J, Ivalo SA, Pierre R, Reyes M, Heather Watts D, Read JS, Mussi-Pinhata MM, Duarte G, Macedo CSV. Maternal antiretroviral use during pregnancy and infant congenital anomalies: the NISDI perinatal study. JAIDS - Journal of Acquired Immune Deficiency Syndromes. 2010 ; 53( 2): 176-185.[citado 2024 ago. 28 ]

Unidades USP

ReP

Filtros

Autores

Autores USP

Assuntos

Indexado em

Afiliação dos autores externos normalizada

Afiliação dos autores externos não normalizada